Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
51,368,292
-
Total 13F shares
-
36,937,639
-
Share change
-
+2,268,210
-
Total reported value
-
$955,518,729
-
Put/Call ratio
-
216%
-
Price per share
-
$25.87
-
Number of holders
-
143
-
Value change
-
+$63,103,719
-
Number of buys
-
95
-
Number of sells
-
37
Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q2 2023
As of 30 Jun 2023 Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) had 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 36,937,639 shares of stock of the company.
Largest 10 holders included Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, NEA Management Company, LLC, BlackRock Inc., Rock Springs Capital Management LP, Novo Holdings A/S, RiverVest Venture Management LLC, VANGUARD GROUP INC, STATE STREET CORP, and CITADEL ADVISORS LLC.
This table shows 143 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.